ADRIBLASTINA Side Effects

6925154-4 | Asthenia, Hiccups, Neutropenia, Stomatitis, Thrombocytopenia, Vomiting
on Aug 04, 2010 Male patient from ITALY , 53 years of age, was diagnosed with nasopharyngeal cancer and was treated with Adriblastina (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, hiccups, neutropenia, stomatitis, thrombocytopenia, vomiting. Adriblastina dosage: 180 Mg Total. During the same period patient was treated with CISPLATIN EBEWE (180 Mg Total) (View Cisplatin Ebewe Review and Cisplatin Ebewe Label ), ENALAPRIL (20 Mg) (View Enalapril Review and Enalapril Label ). Patient was hospitalized.

6921668-1 | Multi-organ Failure, Neutropenia, Sepsis
Patient was taking Adriblastina (View Usage). Patient had the following side effects: multi-organ failure, neutropenia, sepsis (What is sepsis?) on Aug 03, 2010 from ITALY Additional patient health information: Male patient , 64 years of age, was diagnosed with diffuse large b-cell lymphoma, dyslipidaemia and. Adriblastina dosage: 85 Mg, Total. During the same period patient was treated with CYCLOPHOSPHAMIDE (1300 Mg, Total) (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (100 Mg, 1x/day) (View Prednisone Review and Prednisone Label ), VINCRISTINE SULFATE (2 Mg, Total) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), MABTHERA (600 Mg) (View Mabthera Review and Mabthera Label ), TORVAST (20 Mg) (View Torvast Review and Torvast Label ), BROMAZEPAM (15 Drops) (View Bromazepam Review and Bromazepam Label ), OMEPRAZOLE (20 Mg, Unk) (View Omeprazole Review and Omeprazole Label ), LYRICA (150 Mg, Unk) (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

6875870-8 | Multi-organ Failure, Neutropenia, Sepsis
Adverse event was reported on Jul 14, 2010 by a Male patient taking Adriblastina (View Usage) (Dosage: 85 Mg, Total) was diagnosed with diffuse large b-cell lymphoma, dyslipidaemia and. Location: ITALY , 64 years of age, After Adriblastina was administered, patient had the following side effects: multi-organ failure, neutropenia, sepsis (What is sepsis?). During the same period patient was treated with CYCLOPHOSPHAMIDE (1300 Mg, Total) (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (100 Mg, 1x/day) (View Prednisone Review and Prednisone Label ), VINCRISTINE SULFATE (2 Mg, Total) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), MABTHERA (600 Mg) (View Mabthera Review and Mabthera Label ), TORVAST (20 Mg) (View Torvast Review and Torvast Label ), BROMAZEPAM (15 Drops) (View Bromazepam Review and Bromazepam Label ), OMEPRAZOLE (20 Mg, Unk) (View Omeprazole Review and Omeprazole Label ), LYRICA (150 Mg, Unk) (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

6848333-3 | Anaemia, Diarrhoea, Febrile Neutropenia, Renal Failure, Thrombocytopenia
on Jul 06, 2010 Female patient from ITALY , 45 years of age, was diagnosed with non-hodgkin's lymphoma, prophylaxis and was treated with Adriblastina (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, diarrhoea, febrile neutropenia, renal failure, thrombocytopenia. Adriblastina dosage: 100 Mg. During the same period patient was treated with METHOTREXATE SODIUM (12 Mg) (View Methotrexate Sodium Review and Methotrexate Sodium Label ), CYCLOPHOSPHAMIDE (1700 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (2 Mg) (View Vincristine Review and Vincristine Label ), NEULASTA (Unk) (View Neulasta Review and Neulasta Label ).


6840349-6 | Asthenia, Hiccups, Neutropenia, Stomatitis, Thrombocytopenia, Vomiting
on Jul 05, 2010 Male patient from ITALY , 53 years of age, was diagnosed with nasopharyngeal cancer and was treated with Adriblastina (View Usage). Patient had the following side effects: asthenia, hiccups, neutropenia, stomatitis, thrombocytopenia, vomiting. Adriblastina dosage: 180 Mg Total. During the same period patient was treated with CISPLATIN EBEWE (180 Mg Total) (View Cisplatin Ebewe Review and Cisplatin Ebewe Label ), ENALAPRIL (20 Mg) (View Enalapril Review and Enalapril Label ). Patient was hospitalized.

6836409-6 | Hyperpyrexia, Pneumonia
Patient was taking Adriblastina (View Usage). After Adriblastina was administered, patient had the following side effects: hyperpyrexia, pneumonia (What is pneumonia?) on Jul 06, 2010 from ITALY Additional patient health information: Female patient , 73 years of age, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Adriblastina dosage: 40 Mg Cyclic. During the same period patient was treated with BLEOMYCIN (15 Mg Cyclic) (View Bleomycin Review and Bleomycin Label ), VINBLASTINE SULFATE (6 Mg Cyclic) (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), DETICENE (600 Mg, Cyclic) (View Deticene Review and Deticene Label ), ZOFRAN (4 Mg) (View Zofran Review and Zofran Label ), NEULASTA (6 Mg) (View Neulasta Review and Neulasta Label ), ZESTRIL (20 Mg) (View Zestril Review and Zestril Label ). Patient was hospitalized.

6775458-3 | Cardiac Failure, Subendocardial Ischaemia
Adverse event was reported on Jun 07, 2010 by a Male patient taking Adriblastina (View Usage) (Dosage: 75 Mg, Cyclic) was diagnosed with b-cell lymphoma and. Location: ITALY , 83 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure, subendocardial ischaemia. During the same period patient was treated with MABTHERA (750 Mg, Cyclic) (View Mabthera Review and Mabthera Label ), ENDOXAN (1125 Mg, Cyclic) (View Endoxan Review and Endoxan Label ), VINCRISTINE (1.5 Mg, Cyclic) (View Vincristine Review and Vincristine Label ), LASIX (View Lasix Review and Lasix Label ), TRIATEC (View Triatec Review and Triatec Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), MONOKET (View Monoket Review and Monoket Label ). Patient was hospitalized.

6766280-2 | Asthenia, Fluid Intake Reduced, Hyperpyrexia, Hypophagia, Mucosal Inflammation, Respiratory Failure
on May 31, 2010 Male patient from ITALY , 74 years of age, was diagnosed with b-cell lymphoma and was treated with Adriblastina (View Usage). Patient had the following side effects: asthenia, fluid intake reduced, hyperpyrexia, hypophagia, mucosal inflammation, respiratory failure. Adriblastina dosage: 80 Mg Total. During the same period patient was treated with VINCRISTINE (2 Mg Total) (View Vincristine Review and Vincristine Label ), MABTHERA (500 Mg Total) (View Mabthera Review and Mabthera Label ), CYCLOPHOSPHAMIDE (1300 Mg Total) (View Cyclophosphamide Review and Cyclophosphamide Label ), METHYLPREDNISOLONE SODIUM SUCCINATE (60 Mg Total) (View Methylprednisolone Sodium Succinate Review and Methylprednisolone Sodium Succinate Label ), PREDNISONE (100 Mg Total) (View Prednisone Review and Prednisone Label ), ALFUZOSIN HYDROCHLORIDE (View Alfuzosin Hydrochloride Review and Alfuzosin Hydrochloride Label ), ALLOPURINOL (300 Mg) (View Allopurinol Review and Allopurinol Label ), FLUIMUCIL (600 Mg) (View Fluimucil Review and Fluimucil Label ). Patient was hospitalized.

6709620-2 | Hyperpyrexia, Pneumonia
on Apr 23, 2010 Female patient from ITALY , 73 years of age, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and was treated with Adriblastina (View Usage). After Adriblastina was administered, patient had the following side effects: hyperpyrexia, pneumonia (What is pneumonia?). Adriblastina dosage: 40 Mg Cyclic. During the same period patient was treated with BLEOMYCIN (15 Mg Cyclic) (View Bleomycin Review and Bleomycin Label ), VINBLASTINE SULFATE (6 Mg Cyclic) (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), DETICENE (600 Mg, Cyclic) (View Deticene Review and Deticene Label ), ZOFRAN (4 Mg) (View Zofran Review and Zofran Label ), NEULASTA (6 Mg) (View Neulasta Review and Neulasta Label ), ZESTRIL (20 Mg) (View Zestril Review and Zestril Label ). Patient was hospitalized.

6706445-9 | Febrile Neutropenia
Patient was taking Adriblastina (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia on Apr 21, 2010 from ITALY Additional patient health information: Female patient , 65 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Adriblastina dosage: 50 Mg, Cyclic. During the same period patient was treated with CYCLOPHOSPHAMIDE (500 Mg, Cyclic) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6700258-X | Asthenia, Fluid Intake Reduced, Hyperpyrexia, Hypophagia, Mucosal Inflammation, Respiratory Failure
Adverse event was reported on Apr 19, 2010 by a Male patient taking Adriblastina (View Usage) (Dosage: 80 Mg Total) was diagnosed with b-cell lymphoma and. Location: ITALY , 74 years of age, Patient had the following side effects: asthenia, fluid intake reduced, hyperpyrexia, hypophagia, mucosal inflammation, respiratory failure. During the same period patient was treated with VINCRISTINE (2 Mg Total) (View Vincristine Review and Vincristine Label ), MABTHERA (500 Mg Total) (View Mabthera Review and Mabthera Label ), CYCLOPHOSPHAMIDE (1300 Mg Total) (View Cyclophosphamide Review and Cyclophosphamide Label ), METHYLPREDNISOLONE SODIUM SUCCINATE (60 Mg Total) (View Methylprednisolone Sodium Succinate Review and Methylprednisolone Sodium Succinate Label ), PREDNISONE (100 Mg Total) (View Prednisone Review and Prednisone Label ), ALFUZOSIN HYDROCHLORIDE (View Alfuzosin Hydrochloride Review and Alfuzosin Hydrochloride Label ), ALLOPURINOL (300 Mg) (View Allopurinol Review and Allopurinol Label ), FLUIMUCIL (600 Mg) (View Fluimucil Review and Fluimucil Label ). Patient was hospitalized.

6700230-X | Anaemia, Diarrhoea, Febrile Neutropenia, Renal Failure, Thrombocytopenia
on Apr 20, 2010 Female patient from ITALY , 45 years of age, was diagnosed with non-hodgkin's lymphoma, prophylaxis and was treated with Adriblastina (View Usage). After Adriblastina was administered, patient had the following side effects: anaemia, diarrhoea, febrile neutropenia, renal failure, thrombocytopenia. Adriblastina dosage: 100 Mg. During the same period patient was treated with METHOTREXATE SODIUM (12 Mg) (View Methotrexate Sodium Review and Methotrexate Sodium Label ), CYCLOPHOSPHAMIDE (1700 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (2 Mg) (View Vincristine Review and Vincristine Label ), NEULASTA (Unk) (View Neulasta Review and Neulasta Label ).

6692604-0 | Hypoxia, Interstitial Lung Disease
on Apr 12, 2010 Female patient from ITALY , 64 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Adriblastina (View Usage). Patient experienced the following unwanted or unexpected effects: hypoxia, interstitial lung disease. Adriblastina dosage: 80 Mg, Cyclic. During the same period patient was treated with VINCRISTINE (2 Mg, Cyclic) (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (1300 Mg, Cyclic) (View Cyclophosphamide Review and Cyclophosphamide Label ), MABTHERA (View Mabthera Review and Mabthera Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6638076-3 | Febrile Neutropenia
Patient was taking Adriblastina (View Usage). Patient had the following side effects: febrile neutropenia on Mar 05, 2010 from ITALY Additional patient health information: Female patient , 65 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Adriblastina dosage: 50 Mg, Cyclic. During the same period patient was treated with CYCLOPHOSPHAMIDE (500 Mg, Cyclic) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6614180-0 | Febrile Neutropenia
Adverse event was reported on Feb 22, 2010 by a Female patient taking Adriblastina (View Usage) (Dosage: 50 Mg, Cyclic) was diagnosed with breast cancer (What is breast cancer?) and. Location: ITALY , 65 years of age, After Adriblastina was administered, patient had the following side effects: febrile neutropenia. During the same period patient was treated with CYCLOPHOSPHAMIDE (500 Mg, Cyclic) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6608843-0 | Interstitial Lung Disease
on Feb 19, 2010 Female patient from ITALY , 64 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Adriblastina (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Adriblastina dosage: 80 Mg, Cyclic. During the same period patient was treated with VINCRISTINE (2 Mg, Cyclic) (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (1300 Mg, Cyclic) (View Cyclophosphamide Review and Cyclophosphamide Label ), MABTHERA (View Mabthera Review and Mabthera Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.

6567959-8 | Acute Respiratory Failure, Bronchiectasis, Interstitial Lung Disease, Lung Disorder, Septic Shock
on Jan 26, 2010 Male patient from ITALY , 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Adriblastina (View Usage). Patient had the following side effects: acute respiratory failure, bronchiectasis, interstitial lung disease, lung disorder, septic shock. Adriblastina dosage: 90 Mg Cyclic. During the same period patient was treated with VINCRISTINE (1.5 Mg Cyclic) (View Vincristine Review and Vincristine Label ), MABTHERA (690 Mg Cyclic) (View Mabthera Review and Mabthera Label ), CYCLOPHOSPHAMIDE (1380 Mg Cyclic) (View Cyclophosphamide Review and Cyclophosphamide Label ), GRANISETRON (View Granisetron Review and Granisetron Label ), FLEBOCORTID (View Flebocortid Review and Flebocortid Label ), CHLORPHENAMINE MALEATE (View Chlorphenamine Maleate Review and Chlorphenamine Maleate Label ). Patient was hospitalized.

6531963-6 | Erosive Balanitis, Febrile Neutropenia, Stomatitis
Patient was taking Adriblastina (View Usage). After Adriblastina was administered, patient had the following side effects: erosive balanitis, febrile neutropenia, stomatitis on Nov 25, 2009 from ITALY Additional patient health information: Male patient , 63 years of age, was diagnosed with lymphoma (What is lymphoma?), prophylaxis against gastrointestinal ulcer and. Adriblastina dosage: 60 Mg/m2, Cyclic. During the same period patient was treated with VINCRISTINE (1.4 Mg/m2, Cyclic) (View Vincristine Review and Vincristine Label ), MABTHERA (375 Mg/m2, Cyclic) (View Mabthera Review and Mabthera Label ), CYCLOPHOSPHAMIDE (750 Mg/m2, Cyclic) (View Cyclophosphamide Review and Cyclophosphamide Label ), LANSOPRAZOLE (30 Mg) (View Lansoprazole Review and Lansoprazole Label ), PREDNISONE (100 Mg) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6475635-5 | Acute Respiratory Failure, Bronchopneumopathy, Dyspnoea Exertional, Hyperpyrexia, Septic Shock
Adverse event was reported on Nov 24, 2009 by a Male patient taking Adriblastina (View Usage) (Dosage: 90 Mg Cyclic) was diagnosed with non-hodgkin's lymphoma and. Location: ITALY , 60 years of age, Patient experienced the following unwanted or unexpected effects: acute respiratory failure, bronchopneumopathy, dyspnoea exertional, hyperpyrexia, septic shock. During the same period patient was treated with VINCRISTINE (1.5 Mg Cyclic) (View Vincristine Review and Vincristine Label ), MABTHERA (690 Mg Cyclic) (View Mabthera Review and Mabthera Label ), CYCLOPHOSPHAMIDE (1380 Mg Cyclic) (View Cyclophosphamide Review and Cyclophosphamide Label ), GRANISETRON (View Granisetron Review and Granisetron Label ), FLEBOCORTID (View Flebocortid Review and Flebocortid Label ), CHLORPHENAMINE MALEATE (View Chlorphenamine Maleate Review and Chlorphenamine Maleate Label ). Patient was hospitalized.

6368880-0 | Bone Marrow Failure, Neutropenia
on Sep 09, 2009 Female patient from ITALY , 54 years of age, was diagnosed with b-cell lymphoma and was treated with Adriblastina (View Usage). Patient had the following side effects: bone marrow failure, neutropenia. Adriblastina dosage: 100 Mg, Unk. During the same period patient was treated with VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), MABTHERA (View Mabthera Review and Mabthera Label ), DELTACORTENE (View Deltacortene Review and Deltacortene Label ), FLUPHENAZINE DECANOATE (View Fluphenazine Decanoate Review and Fluphenazine Decanoate Label ), CLEXANE (View Clexane Review and Clexane Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.

6313386-8 | Bone Marrow Failure, Neutropenia
on Aug 10, 2009 Female patient from ITALY , 54 years of age, was diagnosed with b-cell lymphoma and was treated with Adriblastina (View Usage). After Adriblastina was administered, patient had the following side effects: bone marrow failure, neutropenia. Adriblastina dosage: 100 Mg, Unk. During the same period patient was treated with VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), MABTHERA (View Mabthera Review and Mabthera Label ), DELTACORTENE (View Deltacortene Review and Deltacortene Label ), FLUPHENAZINE DECANOATE (View Fluphenazine Decanoate Review and Fluphenazine Decanoate Label ), CLEXANE (View Clexane Review and Clexane Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.